Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2012
09/07/2012WO2012116577A1 Chlorogenic acid analogue, preparation process and use thereof
09/07/2012WO2012116447A1 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
09/07/2012WO2012091571A3 Combination of components for the prevention and treatment of frailty
09/07/2012CA2829051A1 Compositions and methods comprising c16:1n7-palmitoleate
09/07/2012CA2828801A1 2-aminothiazole derivative, preparation method, and use
09/07/2012CA2828612A1 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
09/07/2012CA2828572A1 Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
09/07/2012CA2828349A1 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225955 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
09/06/2012US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/06/2012US20120225941 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
09/06/2012US20120225940 Use of (-) (3-Trihalomethylphenoxy) (4-Halophenyl) Acetic Acid Derivatives for Treatment of Insulin Resistance, Type 2 Diabetes, Hyperlipidemia and Hyperuricemia
09/06/2012US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists
09/06/2012US20120225915 Compositions and Methods of Using R(+) Pramipexole
09/06/2012US20120225910 Substituted Heteroaryls
09/06/2012US20120225908 Hydroxyl compounds and compositions for cholesterol management and related uses
09/06/2012US20120225906 Piperidine renin inhibitors
09/06/2012US20120225900 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/06/2012US20120225896 Novel 2-pyridone derivative and pharmaceutical product containing same
09/06/2012US20120225892 [1,5]-Diazocin Derivatives
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/06/2012US20120225887 Glucokinase Activators
09/06/2012US20120225885 Imidazole derivatives and methods of use thereof
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225878 Compounds
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225874 Bicyclic derivatives as cetp inhibitors
09/06/2012US20120225872 Methods of preparing and using quinazoline and quinoline derivatives
09/06/2012US20120225869 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/06/2012US20120225863 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225857 Mst1 kinase inhibitors and methods of their use
09/06/2012US20120225855 Triazolopyridine jak inhibitor compounds and methods
09/06/2012US20120225854 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
09/06/2012US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide
09/06/2012US20120225846 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225840 Hydroxytyrosol combinations for enhancing mitochondrial function and energy production
09/06/2012US20120225813 Compositions, methods and uses for treatment of type 1 diabetes
09/06/2012US20120225812 Substituted fused pyrimidine compounds, its preparation and uses thereof
09/06/2012US20120225811 Insulin analogues
09/06/2012US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient
09/06/2012US20120225146 Composition for alleviating fatty liver
09/06/2012US20120225145 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
09/06/2012US20120225144 Herbal Supplement Prepared From Geranium
09/06/2012US20120225142 Herbal Supplement Prepared From Pelargonium Citronellum
09/06/2012US20120225138 Process utilizing a combination of an acid blend, pectic enzyme and yeast in a wine fermentation container to extract the biologically active compounds from medicinal herbs
09/06/2012US20120225134 Methods and compositions for the treatment and prevention of hypoglycemia and related disorders
09/06/2012US20120225133 Use of an agent that restores tissue perfusion and oxygenation
09/06/2012US20120225131 Methods For Treating Type Diabetes With Brown Adipose Transplants
09/06/2012US20120225120 Stable pharmaceutical composition and methods of using same
09/06/2012US20120225117 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the processes
09/06/2012US20120225100 Articlea and processes for Making a Porous Disintegratable Solid Substrate for Personal Health Care Applications
09/06/2012US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
09/06/2012US20120225096 Immunomodulation using placental stem cells
09/06/2012US20120225088 Compositions and methods for treating cancer and other diseases
09/06/2012US20120225065 Anti-human il-21 monoclonal antibodies
09/06/2012US20120225055 Antigen binding proteins
09/06/2012US20120225054 Use of legume extracts for inducing and enhancing autophagy and apoptosis and for preventing and/or treating cancers
09/06/2012US20120225049 Fast acting snare-cleaving enzymes
09/06/2012US20120225047 Nutrigenetic biomarkers for obesity and type 2 diabetes
09/06/2012US20120225046 Variant form of urate oxidase and use thereof
09/06/2012US20120225037 Sporulation-Deficient B. texasporus Cells and Methods for Efficient and Cost-effective Inactivation and Use Thereof
09/06/2012US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/06/2012US20120225030 Uses of mammalian cytokine; related reagents
09/06/2012US20120225012 Composition for hard tissue repair
09/05/2012EP2495255A1 Glycosylated form of antigenic glp-1 analogue
09/05/2012EP2495238A1 Novel 3-hydroxy-5-arylisoxazole derivative
09/05/2012EP2494983A1 Stable formulations of GLP-1
09/05/2012EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
09/05/2012EP2493889A1 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
09/05/2012EP2493871A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
09/05/2012EP2493497A2 Notch inhibition in the treatment and prevention of obesity and metabolic syndrome
09/05/2012EP2493494A2 Methods and kits for preventing hypoglycemia
09/05/2012EP2493487A1 Composition to induce specific immune tolerance
09/05/2012EP2493482A1 Therapeutic gas for the treatment of mitochondrial disorders
09/05/2012EP2493478A1 Concentrated therapeutic phospholipid compositions
09/05/2012CN1980656B New pharmaceutical use of lipase inhibitor
09/05/2012CN1853666B Pharmaceutical, nutraceutical, dietetic and nutritional compositions based on vegetable fibres
09/05/2012CN1636572B Compositions and methods for treatment of mitochondrial diseases
09/05/2012CN1520424B Immunoglobulins 2
09/05/2012CN102656187A Truncated ActRIIB-FC fusion proteins
09/05/2012CN102656177A Process for preparation of spiroketal derivative
09/05/2012CN102656165A Glycoside derivatives and uses thereof
09/05/2012CN102656163A Heterocyclic compounds for the inhibition of PASK
09/05/2012CN102656160A Benzimidazole analogues for the treatment or prevention of flavivirus infections
09/05/2012CN102656149A Benzamide compound
09/05/2012CN102656147A Spiro indole-cyclopropane indolinones useful as AMPK modulators
09/05/2012CN102656145A Modulators of G protein-coupled receptor 88
09/05/2012CN102656144A Inorganic salt complexes of vildagliptin
09/05/2012CN102655866A Therapeutic or prophylactic agent for diabetes
09/05/2012CN102655767A Liquid food composition
09/05/2012CN102655764A Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight
09/05/2012CN102653515A Polycationic compounds and uses thereof
09/05/2012CN102653514A Chlorogenic acid analog, and preparation method and application thereof
09/05/2012CN102652829A Extraction method of ginseng peptide
09/05/2012CN102652828A Polypeptide-k buccal tablet
09/05/2012CN102652825A Traditional Chinese medicine method for treating II-type diabetes mellitus and traditional Chinese medicine composition
09/05/2012CN102652801A Chinese herbal medicine tea bag for lowering blood sugar and preventing diabetes mellitus complications
09/05/2012CN102652786A Application of total extract composite of Luiwei Dijhuang decoction in preparing medicament for treating diabetic nephropathy
09/05/2012CN102652780A Preparation method of traditional Chinese medicine rhizoma alismatis special-shaped decoction pieces
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 1298